Better Pharmaceuticals for Children Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Better Pharmaceuticals for Children Act - Amends the Federal Food, Drug, and Cosmetic Act to allow for additional deferred effective dates for the approval of certain new drug applications to allow for additional pediatric information developed by further studies. Mandates development, publication, and annual updating of a list of approved drugs for which additional pediatric information may produce health benefits in the pediatric population.
Referred to the Subcommittee on Health and Environment.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 1727: Better Pharmaceuticals for Children Act. 105th Congress. Open America. https://openamerica.io/bill/105-HR-1727/
"H.R. 1727: Better Pharmaceuticals for Children Act." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-HR-1727/.
H.R. 1727, 105th Cong. (2026), https://openamerica.io/bill/105-HR-1727/.
[H.R. 1727: Better Pharmaceuticals for Children Act](https://openamerica.io/bill/105-HR-1727/)